These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31369867)
1. Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis. Proft F; Muche B; Spiller L; Rios Rodriguez V; Rademacher J; Weber AK; Lüders S; Protopopov M; Redeker I; Spiller I; Sieper J; Poddubnyy D Joint Bone Spine; 2020 Jan; 87(1):69-73. PubMed ID: 31369867 [TBL] [Abstract][Full Text] [Related]
2. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study. Kilic E; Kilic G; Akgul O; Ozgocmen S Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469 [TBL] [Abstract][Full Text] [Related]
3. Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study. Proft F; Schally J; Brandt HC; Brandt-Juergens J; Rüdiger Burmester G; Haibel H; Käding H; Karberg K; Lüders S; Muche B; Protopopov M; Rademacher J; Rios Rodriguez V; Torgutalp M; Verba M; Zinke S; Poddubnyy D Ther Adv Musculoskelet Dis; 2022; 14():1759720X221085951. PubMed ID: 35368376 [TBL] [Abstract][Full Text] [Related]
4. Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable? Georgiadis S; Ørnbjerg LM; Michelsen B; Kvien TK; Di Giuseppe D; Wallman JK; Závada J; Provan SA; Kristianslund EK; Rodrigues AM; Santos MJ; Rotar Ž; Pirkmajer KP; Nordström D; Macfarlane GJ; Jones GT; van der Horst-Bruinsma I; Hellamand P; Østergaard M; Hetland ML J Rheumatol; 2024 Jul; 51(7):673-677. PubMed ID: 38621792 [TBL] [Abstract][Full Text] [Related]
5. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis? Kilic G; Kilic E; Ozgocmen S Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497 [TBL] [Abstract][Full Text] [Related]
6. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis. Tsang HHL; Chung HY J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926 [TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore. Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427 [TBL] [Abstract][Full Text] [Related]
8. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study. Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520 [TBL] [Abstract][Full Text] [Related]
9. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS). Solmaz D; Yildirim T; Avci O; Tomas N; Akar S Clin Rheumatol; 2016 Jul; 35(7):1753-8. PubMed ID: 26670454 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study. Kang KY; Ju JH; Park SH; Hong YS J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556 [TBL] [Abstract][Full Text] [Related]
11. [A study on calculating the ankylosing spondylitis disease activity score according to the C-reactive protein level]. Ji X; Du J; Zhu J; Huang F; Zhang J Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):206-10. PubMed ID: 26926373 [TBL] [Abstract][Full Text] [Related]
12. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L; Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245 [TBL] [Abstract][Full Text] [Related]
13. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299 [TBL] [Abstract][Full Text] [Related]
14. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort. Machado P; Navarro-Compán V; Landewé R; van Gaalen FA; Roux C; van der Heijde D Arthritis Rheumatol; 2015 Feb; 67(2):408-13. PubMed ID: 25332195 [TBL] [Abstract][Full Text] [Related]
15. Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values. Cui R; Du Y; Tian N; Jiang HL; Tao YL; Dai SM Clin Exp Rheumatol; 2023 May; 41(5):1163-1169. PubMed ID: 36226617 [TBL] [Abstract][Full Text] [Related]
16. Platelet to albumin ratio is an independent indicator for disease activity in ankylosing spondylitis. Cui R; Wang YL; Tao YL; Tong Q; Chen Z; Dai SM Clin Rheumatol; 2023 Feb; 42(2):407-413. PubMed ID: 36414863 [TBL] [Abstract][Full Text] [Related]
17. Gender difference in ASAS HI among patients with ankylosing spondylitis. Chen HH; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Huang WN; Chen YH PLoS One; 2020; 15(7):e0235678. PubMed ID: 32645080 [TBL] [Abstract][Full Text] [Related]
18. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Salaffi F; De Angelis R; Carotti M; Gutierrez M; Sarzi-Puttini P; Atzeni F Rheumatol Int; 2014 Aug; 34(8):1103-10. PubMed ID: 24509896 [TBL] [Abstract][Full Text] [Related]
19. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study. Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375 [TBL] [Abstract][Full Text] [Related]
20. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers. Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]